Navigation Links
Researchers identify molecules with interesting anti-clotting properties
Date:11/8/2007

RICHMOND, Va. (Nov. 8, 2007) Virginia Commonwealth University researchers have discovered a new mechanism to inhibit key enzymes that play a major role in clotting disorders, which could lead to novel therapies to treat clots in the lungs and those localized deep in the body in areas such as the legs.

Antithrombotic disorders occur when the effect of thrombin, a protein involved in coagulation, is inhibited, rendering blood unable to clot effectively. These disorders are considered common and can be fatal. Additionally, clotting disorders arise due to complications from other diseases like cancer. Although there are a number of anticoagulation drugs available -- heparins and warfarins -- some patients develop adverse reactions to the therapy and must be closely monitored.

In a study published in the Nov. 2 issue of the Journal of Biological Chemistry, Umesh R. Desai, Ph.D., a professor in the Department of Medicinal Chemistry at the VCU School of Pharmacy, lead investigator on the study, reported on the design of three highly complex molecules with unique anticoagulant properties that were prepared in the laboratory. According Desai, these molecules, known as sulfated DHPs, are completely different from anticoagulants used in the clinic today including heparins, coumarins and hirudins.

The team demonstrated that the molecules were able to inhibit the ability of critical enzymes involved with the cascade of events involved in blood clotting. Specifically, the molecules prevent the normal action of thrombin and factor Xa, which are the critical enzymes targeted by current anticoagulant therapy.

We have identified a new mechanism that may prevent clotting. This approach may result in new drugs for the treatment of thrombotic disorders, including pulmonary embolism, deep vein thrombosis and more, said Desai.

The molecules we have designed may possess several advantages compared to currently available anticoagulat
'/>"/>

Contact: Sathya Achia-Abraham
sbachia@vcu.edu
804-827-0890
Virginia Commonwealth University  
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Stanford researchers find culprit in aging muscles that heal poorly
2. UCLA researchers identify markers that may predict diabetes in still-healthy people
3. Mayo Clinic researchers discover new diagnostic test for detecting infection in prosthetic joints
4. Bipolar disorder relapses halved by Melbourne researchers
5. Cell that triggers symptoms in allergy attacks can also limit damage, Stanford researchers find
6. High and mighty: first common height gene identified by researchers behind obesity gene finding
7. Researchers estimate about 9 percent of US children age 8 to 15 meet criteria for having ADHD
8. Majority of 2.4 Million U.S. Children With ADHD Not Diagnosed or Consistently Treated, According to New Gold Standard Study by Cincinnati Childrens Researchers
9. Researchers develop long-lasting growth hormone
10. Jefferson immunology researchers halt lethal rabies infection in brain
11. Purdue researchers develop technology to detect cancer by scanning surface veins
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Researchers identify molecules with interesting anti-clotting properties
(Date:6/18/2013)... "What if adding one simple act ... your health and well-being? Well, there is something easy ... "It is called Skin Brushing ." , Skin ... lost art. Now, people are rediscovering this great health ... so do certain health conscious people. Sublime Beauty® wants ...
(Date:6/18/2013)... New York, New York (PRWEB) June 19, 2013 ... dedicated to protecting the rights of victims injured by ... on behalf of an Arizona woman who alleges that ... The suit was filed on May 30th in the ... Virginia (Civil Action No. 2:13-cv-12677) in the multidistrict litigation ...
(Date:6/18/2013)... Looking for a way to break out of the ... IWALKAWAKE is a guide to unlocking one’s true potential through ... on harnessing the powerful and abundant spiritual presence that is ... guide to finding one’s true purpose and potential. These nine ... to reach their true potential. The awakenings deal with subjects ...
(Date:6/18/2013)... Daily Gossip Magazine has always kept its readers entertained by ... The magazine has decided to prepare readers for the summer ... every week . , According to Daily Gossip ... who are looking to get insights into this type of ... food is almost entirely based on healthy, yet tasteful products. ...
(Date:6/18/2013)... 18, 2013 SEATTLE, WA—A Washington state ... Fairview, Oregon, claiming he fell ill with a hepatitis ... pomegranate seed blend. The complaint was filed in ... Clark, the Seattle-based law firm that has filed ... to the complaint, Brian Brothers consumed “Townsend Farms Organic ...
Breaking Medicine News(10 mins):Health News:The Easiest Way to Contribute to Better Health and Well-Being Starting Today and for Under $20, Says Sublime Beauty® 2Health News:Boston Scientific and American Medical Systems Named in Transvaginal Mesh Lawsuit Filed by Parker Waichman LLP on Behalf of Arizona Woman 2Health News:Boston Scientific and American Medical Systems Named in Transvaginal Mesh Lawsuit Filed by Parker Waichman LLP on Behalf of Arizona Woman 3Health News:Boston Scientific and American Medical Systems Named in Transvaginal Mesh Lawsuit Filed by Parker Waichman LLP on Behalf of Arizona Woman 4Health News:Anabolic Cooking Book Review Exposes Dave Ruel’s Top 10 ‘Anabolicious’ Recipes for BodyBuilders 2Health News:Marler Clark, Washington Resident Sue Townsend Farms Over Hepatitis A 2Health News:Marler Clark, Washington Resident Sue Townsend Farms Over Hepatitis A 3
... Solos Endoscopy, Inc. (Pink Sheets: SNDY) is pleased to ... the first nine months of 2008 on Pinksheets.com for ... the nine-months of 2008 amounted to $304,559, compared with ... substantially lowered its General and Administrative expense by posting ...
... U.S. Surgeon General Kenneth P. Moritsugu urged members of ... nutrition knowledge and patient-care skills to prevent diseases such ... that exist in the United States and to educate ... well-being.Moritsugu, who was Deputy Surgeon General from 1998 to ...
... announced today that Jean-Pierre Lehner , ... (CMO). He was previously Senior Vice President, Medical ... Vice President, Research & Development, who declared: "The ... further demonstration internally and externally of the company,s commitment ...
... Loeppke to discuss recent findings showing that ... medical and pharmacy costs-- Presentation includes real-world ... findings to develop integrated health and productivity ... arthritis and musculoskeletal disorders are significant cost ...
... 11 With a strong corporate commitment ... its partnership with the American Pregnancy Association, which ... "the official omega-3" of their organization. Also known ... leading non-profit in the United States that is ...
... and Drug Administration gave formal approval for the marketing of silicone ... all ages and breast augmentation procedures for patients over the age ... on the safety and effectiveness of silicone implants. , ... ...
Cached Medicine News:Health News:Solos Endoscopy, Inc. Posts First Nine Months Financials for 2008 on Pinksheets.com 2Health News:Registered Dietitians Can Do Much to Help Educate Americans and Eliminate Health Disparities in U.S., Says Former Surgeon General 2Health News:Registered Dietitians Can Do Much to Help Educate Americans and Eliminate Health Disparities in U.S., Says Former Surgeon General 3Health News:Jean-Pierre Lehner Appointed Chief Medical Officer 2Health News:Alere's Dr. Ron Loeppke to Speak on 'Health and Productivity as a Business Strategy' at First Annual IBI/NBCH Health and Productivity Forum 2Health News:Alere's Dr. Ron Loeppke to Speak on 'Health and Productivity as a Business Strategy' at First Annual IBI/NBCH Health and Productivity Forum 3Health News:Nordic Naturals Becomes the Official Omega-3 of the American Pregnancy Association 2Health News:Sacramento Breast Augmentation Surgeon Charles Perry, MD Discusses Silicone Implants on 2-Year Anniversary of FDA Approval 2Health News:Sacramento Breast Augmentation Surgeon Charles Perry, MD Discusses Silicone Implants on 2-Year Anniversary of FDA Approval 3
(Date:6/18/2013)... 2013 Today, Wall Street Reports announced ... GILD ), Health Management Associates Inc. (NYSE: HMA ... Pharmaceuticals Inc. (NASDAQ: ISIS ), and Trius Therapeutics ... of charge - including full price targets, industry analysis and ... Sciences, Inc. Research Report On June 7, 2013, ...
(Date:6/18/2013)... And EMERYVILLE, Calif. ... Inc. presented final results today from a Phase ... release) capsules demonstrating a statistically significant improvement in ... baseline at week 8 versus placebo in the ... investigational extended-release formulation of amantadine intended for once-nightly ...
(Date:6/18/2013)... -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ), the leader ... general corporate update in conjunction with its 2013 Annual Meeting ... 2:10 p.m. Pacific Time in Carlsbad, CA. ... follows: 2:00 p.m. – 2:10 p.m. Annual Meeting of Stockholders ... 2:10 p.m. – 3:15 p.m. Corporate Presentation – Stanley ...
Breaking Medicine Technology:Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 2Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 3Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 4Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 5Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 6Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 2Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 3Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 4Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 5Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 6Isis Pharmaceuticals to Present a General Corporate Update at its 2013 Annual Meeting of Stockholders and Open House 2
Shake 'n' Stack Oven - New Model (includes 10 bottle capacity rotisserie, adjustable feet, drip tray, manual PLUS Shaker Platform)...
Inquire...
... 10.1 kg, Interior Dimensions (WxDxH): 31.1 x ... (WxDxH): 44.6 x 22.4 x 20.5 cm, ... 2 - 300 x 35 mm bottles, ... or 1 - 240 x 80 mm ...
... The Minifold I system consists of four basic ... plenum, and metal clamping plate (see diagram). The ... for producing spots, dots, or slots (see below). ... purchased as an accessory plate in conjunction with ...
Medicine Products: